FDA Investigator Ricki A Chase

Ricki A Chase has inspections in 8 countries as of 06 Oct 2023. Ricki A Chase has collaborated with a combinined 3408 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
128
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada, Germany, Italy, Hungary, Mexico, France, Sweden
Co-Investigator(s):
A Williams, Aaron J Poloni, Alan Escalona, Alan P Kurtzberg, Amanda S Zorn, Andrea J Schmidt, Andrea S Heise, Andrew M Kolenc, Arthur S Williams, Jr, Ashleigh P Barkans, Ashleigh P Wodushek, Becky Bhan, Betty K Baxter, Blake R Jensen, Bodenw, Brent W Higgs, Brent William Higgs, Brian S Erickson, Bryan A Galvez, Bryan J Love, Carlos Chavez, Carolina D Vasquez, Caroline H Le, Catherine J Laufmann, CDR Sean T Creighton, Charles L Larson, Chet A Fitzgerald, Christin L Torres, Christina A Mayer, Christine I Shaw, Christine L Williams, Christine R Casey, Christopher M Jenner, Christopher S Genther, Clinton K George, Courtney R Ingalsbe, Crystal Monroy, Cynthia Jim, CSO, Dale A Nyberg, Dana A Razzano, Daniel J Lahar, Daniel Pst Laurent, Dawn M Braswell, Debra I Love, Debra L Curtis, Denicia L Hernandez, Devaughn Edwards, Don A Leeseberg, Dongping Dai, PhD, Dr. Abhijit Raha, PhD, Dustin M James, Edith M Gonzalez, Elizabeth D Connell, Elvin R Smith, Emily B Camire, Eric W Anderson, Erika V Butler, Felicia M Orlando, Felix J Marrero, Franklin D Heisler, Gary C Pecic, Gerard T Schneider, Ginger M Sykes, Gladys B Casper, Gloria A Milster, Grace E Mcnally, Gregson A Joseph, Hanna L Potter, Haroon Vohra (NMI), Harperd, Holly L Miller, Isabel Y Espinosa, Jacqueline Mdiaz Albertini, James A Beaulieu, James P Stallings, James R Montero, Jamie L Dion, Janet Pulver, Janice L Straight, Jennifer A Robinson, Jennifer L Wolfe, Jesse A Vazquez, Jessica L Pressley, Jessie E Morris, Joel D Hustedt, John A Gonzalez, Jonathan R Campos, Joy Rkozlowski Klena, Juan A Morales, Kamara Co, Karen A Coleman, Katherine Szestypalow, Kathleen S Tormey, Kathryn M Megen, Kathryn M Mogen, Kelly D Moore, Kent C Faul, Kimberley A Hoefen, Kimberly Lewandowski Walker, Kimetha A King, Kinh Q Mac, Kirtida Patel, Kristen E Szenderski, Kristi B Panzer, Lance D Johnson, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, LCDR Matthew J Morrison, Leonard H Lavi, Lewis K Antwi, Linda Agregory Duty, Linda F Murphy, Linda M Cheny, Lori A Carr, Lori A Medina, Lourdes Andujar, Manuel A Moreno, Marc A Jackson, Jr, Margaret M Annes, Marie Bbuen Bigornia, Marijo B Kambere, PhD, Marion W Nadeau, Marsha L Mccauley, Mary F Bodick, Matthew A Johnson, Matthew A Walburger, Matthew J Hansen, Matthew M Vernon, Matthew R Clabeaux, Matthew R Dionne, Melissa F Chauvin, Michael A Charles, Michael J Kuchta, Michael R Goga, Mihaly S Ligmond, Monica J Wilkins, Mpris Inspector, Nancy Bogdanovic, Nancy G Schmidt, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nicholas L Hunt, Nicholas R Nance, Norman Wong, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Paul Z Balcer, Phillip M Pontikos, Ralph Jerndal, Ramesh Raghavachari, Rebecca E Dombrowski, Rebecca L Stephany, Rebecca S Secrist, Richard K Vogel, Richard W Clark, Ricki Achase Off, Robert J Martin, Saied A Asbagh, Samina S Khan, Santiago Gallardo Johnson, Secrist, Shelley H Beausoleil, Shererk, Simone E Pitts, Srinivas R Chennamaneni, PhD, Stanley B Eugene, BS, BME, State Agency, Stephen T Hansen, Steven C Madzo, Susan L Young, Susan M Jackson, Teena H Aiken, Tenzin Jangchup, Teresa I Navas, Teresa K Kastner, Thaddeus M Steinke, Thai T Duong, Theressa B Smith, Uduak M Inokon, Vicky L Cruz, Wayne W Grundstrom, William A Lanier, William R Chang, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm

Ricki A Chase's Documents

Publish Date Document Type Title
October, 2004 FDA 483 Response Wasatch Product Development, LLC. - Form 483R, 2004-12-15
September, 2003 FDA 483 Becton Dickinson and Company - Form 483, 2003-09-24
December, 2000 FDA 483 Isomedix Operations, Inc. - Form 483, 2000-12-21
June, 2002 FDA 483 Jubilant HollisterStier General Partnership. - Form 483, 2002-06-21
August, 2003 FDA 483 Cardinal Health - Form 483, 2003-08-07
November, 2001 EIR ICU Medical, Inc. - EIR, 2001-11-20
December, 2004 EIR GE OEC Medical Systems, Inc - EIR, 2004-12-01
May, 2004 FDA 483 Inceptio Medical Technologies, L.C. - Form 483, 2004-05-07
August, 2003 EIR Biosense Webster, Inc. - EIR, 2003-08-14
December, 2004 FDA 483 Merit Medical Systems, Inc. - Form 483, 2004-12-10
March, 2003 EIR Utah Medical Products, Inc - EIR, 2003-03-12
February, 2003 EIR RB Health Manufacturing (US) LLC - EIR, 2003-02-20
April, 2002 FDA 483 Utah Medical Products, Inc - Form 483, 2002-04-15
April, 2004 EIR Nutraceutical International Corporation - EIR, 2004-04-26
March, 2005 FDA 483 Cody Laboratories, Inc. - Form 483, 2005-03-17
May, 2003 EIR NSE Products, Inc. - EIR, 2003-05-06
December, 2010 FDA 483 Zevex Incorporated (dba MOOG Medical Devices Group) - Form 483, 2010-12-29
July, 2004 FDA 483 Nelson Laboratories, LLC - Form 483, 2004-07-30
December, 2004 FDA 483 GE OEC Medical Systems, Inc - Form 483, 2004-12-01
March, 2003 FDA 483 Utah Medical Products, Inc - Form 483, 2003-03-12
June, 2002 FDA 483 Response Jubilant HollisterStier General Partnership. - Form 483R, 2002-07-16
October, 2004 FDA 483 Wasatch Product Development, LLC. - Form 483, 2004-10-29
October, 2004 EIR Wasatch Product Development, LLC. - EIR, 2004-10-29
November, 2001 FDA 483 ICU Medical, Inc. - Form 483, 2001-11-20
June, 2002 EIR Jubilant HollisterStier General Partnership. - EIR, 2002-06-21
February, 2004 FDA 483 Lumenis, Inc. - Form 483, 2004-02-27
April, 2002 EIR Utah Medical Products, Inc - EIR, 2002-04-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more